Cargando…

Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease

OBJECTIVES: Obesity measurement indexes have certain screening value for metabolic diseases. To investigate associations between metabolic associated fatty liver disease (MAFLD) and obesity measurement indexes, including traditional indexes (BMI, WC, WHtR) and new indexes (ABSI, BRI, VAI, LAP), and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongyan, Zhang, Yuxue, Liu, Yupeng, Li, Hui, Xu, Ruiling, Fu, Hongmei, Yan, Chaoqi, Qu, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160459/
https://www.ncbi.nlm.nih.gov/pubmed/37152940
http://dx.doi.org/10.3389/fendo.2023.1163682
_version_ 1785037283238346752
author Wang, Hongyan
Zhang, Yuxue
Liu, Yupeng
Li, Hui
Xu, Ruiling
Fu, Hongmei
Yan, Chaoqi
Qu, Bo
author_facet Wang, Hongyan
Zhang, Yuxue
Liu, Yupeng
Li, Hui
Xu, Ruiling
Fu, Hongmei
Yan, Chaoqi
Qu, Bo
author_sort Wang, Hongyan
collection PubMed
description OBJECTIVES: Obesity measurement indexes have certain screening value for metabolic diseases. To investigate associations between metabolic associated fatty liver disease (MAFLD) and obesity measurement indexes, including traditional indexes (BMI, WC, WHtR) and new indexes (ABSI, BRI, VAI, LAP), and assess their screening ability. METHODS: 12,658 subjects aged 18-75 at the Health Center of a Class III Grade A Hospital were included, who were divided into MAFLD and non-MAFLD groups. Spearman’s rank correlation was used to study the correlation between MAFLD and obesity measurement indexes. Receiver operating characteristic (ROC) curves were used to calculate the area under the curve (AUC) to evaluate their screening accuracy. RESULTS: MAFLD had strong correlation with traditional BMI and new index LAP. ROC analysis showed that BMI had the highest AUC (0.89), followed by LAP (0.87). Stratification by BMI, LAP had the highest AUC (0.90) for MAFLD in population without obesity (BMI< 23kg/m(2)), and its optimal cutoff value was 20.75, with a sensitivity and specificity of 85.9% and 79.0%, respectively. CONCLUSIONS: We proposed a two-step screening strategy for MAFLD, combining BMI and LAP, and defined a high-risk population for MAFLD as follows: 1) BMI ≥ 23 kg/m(2); and 2) BMI< 23 kg/m(2) and LAP ≥ 20.75.
format Online
Article
Text
id pubmed-10160459
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101604592023-05-06 Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease Wang, Hongyan Zhang, Yuxue Liu, Yupeng Li, Hui Xu, Ruiling Fu, Hongmei Yan, Chaoqi Qu, Bo Front Endocrinol (Lausanne) Endocrinology OBJECTIVES: Obesity measurement indexes have certain screening value for metabolic diseases. To investigate associations between metabolic associated fatty liver disease (MAFLD) and obesity measurement indexes, including traditional indexes (BMI, WC, WHtR) and new indexes (ABSI, BRI, VAI, LAP), and assess their screening ability. METHODS: 12,658 subjects aged 18-75 at the Health Center of a Class III Grade A Hospital were included, who were divided into MAFLD and non-MAFLD groups. Spearman’s rank correlation was used to study the correlation between MAFLD and obesity measurement indexes. Receiver operating characteristic (ROC) curves were used to calculate the area under the curve (AUC) to evaluate their screening accuracy. RESULTS: MAFLD had strong correlation with traditional BMI and new index LAP. ROC analysis showed that BMI had the highest AUC (0.89), followed by LAP (0.87). Stratification by BMI, LAP had the highest AUC (0.90) for MAFLD in population without obesity (BMI< 23kg/m(2)), and its optimal cutoff value was 20.75, with a sensitivity and specificity of 85.9% and 79.0%, respectively. CONCLUSIONS: We proposed a two-step screening strategy for MAFLD, combining BMI and LAP, and defined a high-risk population for MAFLD as follows: 1) BMI ≥ 23 kg/m(2); and 2) BMI< 23 kg/m(2) and LAP ≥ 20.75. Frontiers Media S.A. 2023-04-21 /pmc/articles/PMC10160459/ /pubmed/37152940 http://dx.doi.org/10.3389/fendo.2023.1163682 Text en Copyright © 2023 Wang, Zhang, Liu, Li, Xu, Fu, Yan and Qu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Wang, Hongyan
Zhang, Yuxue
Liu, Yupeng
Li, Hui
Xu, Ruiling
Fu, Hongmei
Yan, Chaoqi
Qu, Bo
Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease
title Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease
title_full Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease
title_fullStr Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease
title_full_unstemmed Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease
title_short Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease
title_sort comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160459/
https://www.ncbi.nlm.nih.gov/pubmed/37152940
http://dx.doi.org/10.3389/fendo.2023.1163682
work_keys_str_mv AT wanghongyan comparisonbetweentraditionalandnewobesitymeasurementindexforscreeningmetabolicassociatedfattyliverdisease
AT zhangyuxue comparisonbetweentraditionalandnewobesitymeasurementindexforscreeningmetabolicassociatedfattyliverdisease
AT liuyupeng comparisonbetweentraditionalandnewobesitymeasurementindexforscreeningmetabolicassociatedfattyliverdisease
AT lihui comparisonbetweentraditionalandnewobesitymeasurementindexforscreeningmetabolicassociatedfattyliverdisease
AT xuruiling comparisonbetweentraditionalandnewobesitymeasurementindexforscreeningmetabolicassociatedfattyliverdisease
AT fuhongmei comparisonbetweentraditionalandnewobesitymeasurementindexforscreeningmetabolicassociatedfattyliverdisease
AT yanchaoqi comparisonbetweentraditionalandnewobesitymeasurementindexforscreeningmetabolicassociatedfattyliverdisease
AT qubo comparisonbetweentraditionalandnewobesitymeasurementindexforscreeningmetabolicassociatedfattyliverdisease